Evidence map›Paper›PMID 35974041›Full record

ArticleScientific reports2022

Pinocembrin suppresses oxidized low-density lipoprotein-triggered NLRP3 inflammasome/GSDMD-mediated endothelial cell pyroptosis through an Nrf2-dependent signaling pathway.

Tong Wang, Hua Tian, Tianqi Pan, Shutong Yao, Huayun Yu, Yumei Wu, Shijun Wang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. Review of OxLDL Driven Inflammatory Cell Activation.Current atherosclerosis reports · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Mitochondria as a Therapeutic Target in Metabolic Disorders.Mini reviews in medicinal chemistry · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Tong Wang *College of Nursing, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, China.
Hua Tian *College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, No. 4655 Daxue Road, Changqing District, Jinan, 250355, Shandong, China. liutianfangyu@163.com.
Tianqi PanCollege of Basic Medical Sciences, Shandong Academy of Medical Sciences, Shandong First Medical University, Taian, 271000, Shandong, China.
Shutong YaoCollege of Basic Medical Sciences, Shandong Academy of Medical Sciences, Shandong First Medical University, Taian, 271000, Shandong, China.
Huayun YuCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, No. 4655 Daxue Road, Changqing District, Jinan, 250355, Shandong, China.
Yumei WuPharmacy Department, Dongying District Hospital of Traditional Chinese Medicine, Dongying, 257000, Shandong, China.
Shijun WangCollege of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, No. 4655 Daxue Road, Changqing District, Jinan, 250355, Shandong, China. wsj@sdutcm.edu.cn.
Shandong University of Traditional Chinese Medicine · CNShandong First Medical University · CNDongyang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pinocembrin (Pin) has been confirmed to exert anti-inflammatory and antiatherosclerotic effects. Here we have explored whether and how Pin would protect vascular endothelial cells against pyroptosis elicited by the exposure to oxidized low density lipoprotein (oxLDL). Our results showed that Pin preconditioning dose-dependently suppressed oxLDL-stimulated HUVEC injury and pyroptosis, which were manifested by improved cell viability, lower lactate dehydrogenase (LDH) levels and DNA damage as well as decreased expression of pyroptosis-related markers, such as NOD-like receptor pyrin domain-containing 3 (NLRP3), apoptosis-associated speck-like protein containing a caspase activation and recruitment domain (ASC), pro-Caspase-1, cleaved Caspase-1, N-terminus of Gasdermin D-N (GSDMD-N), pro-interleukins-1β (pro-IL-1β), IL-1β and inflammatory cytokines (IL-18 and IL-1β). All of the effects were similar to those of MCC950 (an NLRP3 inhibitor). As expected, Pin distinctly activated the Nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidative signaling pathway assessed through increased expressions of Nrf2, heme oxygenase-1 (HO-1) and NAD(P)H quinone oxidoreductase 1 (NQO1). Furthermore, after transfection with small interfering RNA of Nrf2, the inhibitory effects of Pin on oxLDL-triggered NLRP3 inflammasome/GSDMD-mediated pyroptosis and oxidative stress in HUVECs were weakened. Additionally, Pin up-regulated Nrf2/HO-1 axis and down-regulated NLRP3 inflammasome/GSDMD-mediated pyroptosis signals in Apoe

Indexed as

InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinAnimalsCaspase 1Endothelial CellsFlavanonesLipoproteins, LDLMiceNF-E2-Related Factor 2Signal TransductionCaspase 1FlavanonesInflammasomesLipoproteins, LDLNF-E2-Related Factor 2NLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mouseoxidized low density lipoproteinpinocembrin

Identifiers

PMID35974041
PMCPMC9381505
OpenAlexW4291993632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.